{
  "id": 20790073,
  "title": "Sanofi's Infilbray wins first approval for neurological symptoms of Gaucher",
  "url": "https://urgent.news/2026/11/19/sanofis-infilbray-wins-first-approval-for-neurological-symptoms-of",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-19T19:18:12.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/sanofis-infilbray-wins-first-approval-for-neurological-symptoms-of-gaucher/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Sanofi won approval Wednesday for Infilbray, the first drug in the US to treat the neurological symptoms of a rare genetic disorder called Gaucher disease. Infilbray, also known as venglustat, crosses the blood-brain barrier to ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "BioPharma Dive",
        "title": "Sanofi gains FDA clearance for Gaucher disease pill",
        "url": "https://urgent.news/2026/11/19/sanofi-gains-fda-clearance-for-gaucher-disease-pill",
        "published": "2026-11-19T17:17:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}